A detailed history of Cullen/Frost Bankers, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 102,509 shares of LLY stock, worth $81.6 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
102,509
Previous 102,851 0.33%
Holding current value
$81.6 Million
Previous $93.1 Million 2.47%
% of portfolio
1.26%
Previous 1.36%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$772.14 - $960.02 $264,071 - $328,326
-342 Reduced 0.33%
102,509 $90.8 Million
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $1 Million - $1.26 Million
-1,386 Reduced 1.33%
102,851 $93.1 Million
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $2.49 Million - $3.33 Million
-4,204 Reduced 3.88%
104,237 $81.1 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $4.01 Million - $4.73 Million
-7,638 Reduced 6.58%
108,441 $63.2 Million
Q3 2023

Nov 02, 2023

SELL
$434.7 - $599.3 $869,834 - $1.2 Million
-2,001 Reduced 1.69%
116,079 $62.3 Million
Q2 2023

Aug 04, 2023

SELL
$350.74 - $468.98 $953,311 - $1.27 Million
-2,718 Reduced 2.25%
118,080 $55.4 Million
Q1 2023

May 05, 2023

SELL
$310.63 - $364.82 $80,453 - $94,488
-259 Reduced 0.21%
120,798 $41.5 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $2.64 Million - $3.07 Million
8,205 Added 7.27%
121,057 $44.3 Million
Q3 2022

Nov 07, 2022

BUY
$296.48 - $337.87 $1.07 Million - $1.22 Million
3,624 Added 3.32%
112,852 $36.5 Million
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $747,275 - $877,410
2,681 Added 2.52%
109,228 $35.4 Million
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $611,367 - $759,774
2,605 Added 2.51%
106,547 $30.5 Million
Q4 2021

Feb 07, 2022

SELL
$224.85 - $279.04 $681,295 - $845,491
-3,030 Reduced 2.83%
103,942 $28.7 Million
Q3 2021

Nov 04, 2021

BUY
$221.6 - $272.71 $1.01 Million - $1.25 Million
4,571 Added 4.46%
106,972 $24.7 Million
Q2 2021

Aug 05, 2021

SELL
$180.55 - $233.54 $658,285 - $851,486
-3,646 Reduced 3.44%
102,401 $23.5 Million
Q1 2021

May 05, 2021

BUY
$164.32 - $212.72 $26,455 - $34,247
161 Added 0.15%
106,047 $19.8 Million
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $818,897 - $1.08 Million
6,277 Added 6.3%
105,886 $17.9 Million
Q3 2020

Nov 05, 2020

BUY
$146.22 - $169.13 $11.1 Million - $12.9 Million
76,092 Added 323.56%
99,609 $14.7 Million
Q2 2020

Aug 05, 2020

SELL
$136.42 - $164.18 $53,613 - $64,522
-393 Reduced 1.64%
23,517 $3.86 Million
Q1 2020

May 01, 2020

SELL
$119.05 - $147.35 $114,407 - $141,603
-961 Reduced 3.86%
23,910 $3.32 Million
Q4 2019

Feb 06, 2020

SELL
$106.92 - $132.43 $128,838 - $159,578
-1,205 Reduced 4.62%
24,871 $3.27 Million
Q3 2019

Nov 01, 2019

SELL
$106.79 - $116.16 $178,339 - $193,987
-1,670 Reduced 6.02%
26,076 $2.92 Million
Q2 2019

Aug 01, 2019

SELL
$110.79 - $129.32 $80,765 - $94,274
-729 Reduced 2.56%
27,746 $3.07 Million
Q1 2019

Apr 30, 2019

SELL
$111.31 - $131.02 $339,050 - $399,086
-3,046 Reduced 9.66%
28,475 $3.7 Million
Q4 2018

Feb 06, 2019

BUY
$105.9 - $118.64 $835,551 - $936,069
7,890 Added 33.39%
31,521 $3.65 Million
Q3 2018

Oct 29, 2018

SELL
$85.86 - $107.31 $130,850 - $163,540
-1,524 Reduced 6.06%
23,631 $2.54 Million
Q2 2018

Jul 27, 2018

SELL
$75.7 - $86.88 $80,771 - $92,700
-1,067 Reduced 4.07%
25,155 $2.15 Million
Q1 2018

May 11, 2018

SELL
$74.21 - $87.6 $315,021 - $371,862
-4,245 Reduced 13.93%
26,222 $2.03 Million
Q4 2017

Jan 31, 2018

SELL
$81.94 - $87.89 $37,856 - $40,605
-462 Reduced 1.49%
30,467 $2.57 Million
Q3 2017

Nov 02, 2017

BUY
$77.07 - $85.54 $2.38 Million - $2.65 Million
30,929
30,929 $2.65 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.